Analytical Data
-
基因名
CDR1
- Application
-
别名
CDR34
-
种属
Human
-
表达系统
Yeast
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P51861
-
表达区间
1-262aa
-
分子量
32.6
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CDR1 (cytochrome c reductase 1) is a pivotal protein involved in various biological processes, including electron transport in mitochondria. Understanding CDR1's structure and function is crucial for elucidating its role in cellular respiration and energy metabolism. Recent research has highlighted its importance in various pathological conditions, including neurodegenerative diseases and metabolic disorders. Recombining CDR1 allows for the investigation of its functional properties and interactions with other cellular components. Moreover, the recombinant form of CDR1 can serve as a valuable tool in studying its enzymatic activity and potential as a therapeutic target. Advances in recombinant DNA technology have enabled the production of CDR1 in heterologous systems, facilitating large-scale purification and characterization. This progress opens the door for innovative approaches to drug design and development aimed at modulating CDR1 activity in disease states. Understanding the molecular mechanisms of CDR1 can ultimately contribute to the development of novel therapeutic strategies and enhance our comprehension of mitochondrial function and its broader implications in health and disease.
